Supplementary Figure 4 from Systemic Immunotherapy of Non-Muscle Invasive Mouse Bladder Cancer with Avelumab, an Anti–PD-L1 Immune Checkpoint Inhibitor
Year: 2023
Type: supplementary-materials
Abstract: Immunohistochemical detection of CD4 and CD8 immune cell subsets in the bladders of mice treated with Avelumab, BCG or Avelumab plus BCG
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362539929